Introduction
The need for measures of outcome for use in the health service is widely recognized. However, to date most of the focus has been directed towards establishing the validity and reliability of instruments rather than their responsiveness or sensitivity to changes in health over time.' 2 Since the purpose of an outcome measure is to quantify the effect of health care, any instrument that is intended for use as an outcome measure in the health service must be shown to be responsive to clinically important changes in patients' perceived health.
Although generally agreed methods exist for assessing validity and reliability, there is less consensus in assessing the responsiveness of outcome measures. Previous work has related change scores on outcome measures to external criteria and processes of care. The degree of concordance between change scores and external criteria has been assessed with transition questions,3 4 which ask the patient or clinician whether there has been a change in health over some given period and in clinical data -for example, erythrocyte sedimentation rate in rheumatoid arthritis.5 Several studies examined changes in outcome variables after interventions of known efficacy, including total joint arthroplasty6 and total hip arthroplasty.7 Different methods have also been proposed for quantifying the responsiveness of outcome measures. These include receiver operator characteristic curves,4 responsiveness indices,9 effect sizes,'0 and standardized response means. 6 The SF 36 health survey questionnaire" 12 has been shown to be valid and reliable in the United States'2 13 and in populations in the United Kingdom."'4-' However, only two published studies in the United States examined the ability of the questionnaire to detect changes in health status over time.7 18 In the first study7 the 108 item sickness impact profile,'9 previously shown to be responsive by demonstrating significant improvements in patients undergoing joint arthroplasty,20 was administered with the SF 36 questionnaire preoperatively and postoperatively to patients undergoing total hip arthroplasty. The SF 36 questionnaire was as responsive as the longer sickness impact profile to changes in health status after surgery. In the second study, the SF 36 questionnaire was administered to patients before and after heart valve replacement surgery.'8 Patients' scores were compared with scores for the general population after correcting for sex and age. Before surgery, compared with the general population, the patients had lower scores across the eight scales of the SF 36 questionnaire and scored particularly low on the scales of physical functioning, role limitations, and energy and fatigue. One month after surgery patients'
Responsiveness of SF 36 health survey questionnaire to changes in health status scores remained below those of the general population on all but the scale of general health perception, and six months after surgery they approximated to those of the general population on all but the scales of role limitations.
If the SF 36 questionnaire is to be adopted as a measure of outcome for use in the NHS its ability to detect changes in health status for patient populations in the United Kingdom needs to be assessed. We report the results of a study in which the questionnaire was administered to a large sample of patients in the United Kingdom with four common conditions -low back pain, menorrhagia, suspected peptic ulcer, and varicose veins -who were followed up for a year. For the eight scales of the questionnaire change scores were calculated and compared with patient responses on a transition question. A standardized measure was used to quantify responsiveness, and patient scores at baseline and follow up were compared with those of the general population.
Methods

SAMPLING AND DATA COLLECTION
The methods of identifying and recruiting patients were as described in the previous paper (p 180)17 in relation to study 1. In this paper we assessed the responsiveness of the SF 36 questionnaire by sending a follow up questionnaire to patients taking part in study 1 at one year. A random sample of 900 members of the general population, selected from the electoral register for Aberdeen, served as a comparison group; they were sent a similar questionnaire. 16 24 Referred patients have a lower perceived health status than those being managed solely in general practice. 16 In this study we compared referred and non-referred patients for changes in their perceived health status over one year. Regression analysis was used to estimate the effect of referral on health status at baseline and follow up for each of the four conditions after correcting for age, sex and socioeconomic status.
The results are presented as absolute and standard scores at baseline for a member of the general population with average characteristics and at baseline and after one year's follow up for members of the four patient groups with the same characteristics. Absolute scores, presented as mean deviations from the scores of the general population, allow comparisons between the patient groups and the general population for each individual SF 36 scale. Standard scores are calculated by dividing the differences between the scores for each patient group with a specific condition and for the general population by the standard deviation of the score for general population. Presented as line graphs, these standard scores allow comparisons between the patient groups and the general population at baseline and after one year's follow up across the entire SF 36 health questionnaire profile.
Results
RESPONSE RATE
The results of the recruitment of patients are described in the previous paper (p 180) in relation to study 1 To facilitate interpretation of baseline and follow up scores they were compared with data for the general population of Aberdeen. The mean baseline scores for the general population and the mean score deviations for the condition specific groups after correcting -1-6(1-7)
Mean score for a given patient group can be calculated by adding the mean deviation to the mean score for the general population. Adding the change score in parentheses gives the mean score at 12 months' follow up.
Significant score differences from the general population and significant change scores: Ip < 0-05; t# < 0-01; tp < 0-005; *p < 0-001. In this study changes in all eight SF 36 scales were significantly related to changes in self reported health as measured by the transition question in the questionnaire. Standardised response means, a measure of an instrument's responsiveness to change, were calculated for each SF 36 scale. The group of patients reporting their health as much better on the transition question had the largest standardized response means, followed by those reporting their health to be somewhat better and, lastly, by those reporting their health to be about the same.
To estimate the burden of each particular condition on health status and to assess the extent of any improvement, patients' scores on the eight scales of the questionnaire at baseline and follow up were compared with the scores for the local general population. Across all eight questionnaire scales mean improvements in health status were seen for all four conditions, which were in line with the responses to the transition question. For two conditions -namely, varicose veins and suspected peptic ulcer -the SF 36 health profiles at follow up were close to the health profile for the general population. This finding suggests that for the average patient with suspected peptic ulcer or varicose veins the health outcome at one year was to achieve a standard of health that closely approximates to that experienced by the average member of the general population. For patients with low back pain and menorrhagia changes in scores suggest the outcome is relatively less favourable. Although significant improvements in questionnaire scores were seen for these patients, particularly for pain in patients with low back pain and energy and fatigue in women with menorrhagia, the average patients' score still deviated considerably from that for the average member of the general population, on all eight health scales in the case of low back pain and on all but the physical and social functioning scales in the case of menorrhagia. We emphasise that it has not been possible in a study of this kind to attribute with certainly the health outcomes detected by the SF 36 questionnaire to the medical care received. We were concerned with evaluating the responsiveness of the SF 36 questionnaire and not the effectiveness of treatments. To carry out such an evaluation would require us to relate more precisely the processes of care for individual patients to the outcome achieved, controlling for other variables that may influence health. The alternative would be to conduct a randomised controlled trial of treatment using the SF 36 questionnaire as part of a package of outcome measures. Such a package would also include more traditional clinical indicators and a condition specific measure.30 For certain conditions, condition specific measures have been shown to be more responsive than the SF 36 questionnaire to small, but clinically significant, changes over time, with greater power to discriminate between patients with very severe or very mild disease.3' They also provide additional information on symptomatology which may be relevant to clinicians.
For a measure of health status and health outcome to be suitable for routine use within the NHS in a wide variety of clinical settings it must provide information that is valid, reliable, responsive to change, and quick and easy to collect. Our findings here and in the accompanying article suggest that the SF 36 questionnaire is responsive to clinical change and sufficiently reliable'7 for monitoring groups of patients and, for at least four of its scales, individual patients.
In conclusion, the SF 36 questionnaire is responsive to changes in health status over time, even when used to assess health improvements in patients with relatively minor clinical conditions. Taken together with previously published data on validity and reliability, our results provide further evidence for the potential of the SF 36 questionnaire as a routine tool in monitoring and assessment of health outcome in the NHS and as an evaluative instrument in clinical research for a wide range of conditions.
